RecruitingNCT02755974

The London COPD Exacerbation Cohort

Relationship Between Patient Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease.


Sponsor

Imperial College London

Enrollment

300 participants

Start Date

Jan 1, 2009

Study Type

OBSERVATIONAL

Conditions

Summary

The London COPD exacerbation (EXCEL) cohort builds on an established cohort started in 1995 and designed to study COPD exacerbations and their impact on health-status and disease progression.


Eligibility

Min Age: 40 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is following patients with COPD (chronic obstructive pulmonary disease — a progressive lung condition that makes breathing increasingly difficult) over time to understand what triggers flare-ups, how the body responds, and what helps recovery. **You may be eligible if...** - You have COPD confirmed by a breathing test showing reduced airflow (FEV1/FVC ratio below 0.70) - You are willing to give written consent - You are 40 years or older **You may NOT be eligible if...** - You have a history of asthma, bronchiectasis (widened airways), lung cancer, or another significant lung condition - You take immunosuppressive medications or have active cancer - You are on long-term oral steroid therapy - You are under 40 years old Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Heart and Lung Institute, Imperial College

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02755974


Related Trials